Page last updated: 2024-09-05

gvs 111 and scopolamine hydrobromide

gvs 111 has been researched along with scopolamine hydrobromide in 2 studies

Compound Research Comparison

Studies
(gvs 111)
Trials
(gvs 111)
Recent Studies (post-2010)
(gvs 111)
Studies
(scopolamine hydrobromide)
Trials
(scopolamine hydrobromide)
Recent Studies (post-2010) (scopolamine hydrobromide)
912317,5485631,401

Protein Interaction Comparison

ProteinTaxonomygvs 111 (IC50)scopolamine hydrobromide (IC50)
Muscarinic acetylcholine receptor M4Homo sapiens (human)0.003
Muscarinic acetylcholine receptor M1Rattus norvegicus (Norway rat)0.006
Muscarinic acetylcholine receptor M3Rattus norvegicus (Norway rat)0.006
Muscarinic acetylcholine receptor M4Rattus norvegicus (Norway rat)0.006
Cytochrome P450 3A4Homo sapiens (human)0.0006
Muscarinic acetylcholine receptor M5Rattus norvegicus (Norway rat)0.006
Muscarinic acetylcholine receptor M2Rattus norvegicus (Norway rat)0.006
Muscarinic acetylcholine receptor M1Homo sapiens (human)0.0026

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Belnik, AP; Ostrovskaya, RU; Poletaeva, II1
Belnik, AP; Ostrovskaya, RU; Radionova, KS1

Other Studies

2 other study(ies) available for gvs 111 and scopolamine hydrobromide

ArticleYear
Dipeptide preparation Noopept prevents scopolamine-induced deficit of spatial memory in BALB/c mice.
    Bulletin of experimental biology and medicine, 2007, Volume: 143, Issue:4

    Topics: Animals; Dipeptides; Male; Maze Learning; Memory; Mice; Mice, Inbred BALB C; Neuroprotective Agents; Nootropic Agents; Scopolamine; Space Perception

2007
Original nootropic drug noopept prevents memory deficit in rats with muscarinic and nicotinic receptor blockade.
    Bulletin of experimental biology and medicine, 2008, Volume: 146, Issue:1

    Topics: Animals; Cholinergic Agonists; Cholinergic Antagonists; Dipeptides; Male; Mecamylamine; Memory; Memory Disorders; Nicotinic Antagonists; Nootropic Agents; Rats; Scopolamine

2008